Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Motor Neuron Disease (MND) is a progressive neurodegenerative disease that dramatically shortens the lives of the majority of those who develop it because there is no effective disease-modifying treatment as yet. It causes relentless weakness in the limbs and often speech and swallowing muscles, with loss of independence and eventual respiratory failure. Those who develop MND have typically led healthy, active lives, and only a minority have a family history ofthe disease or the related condition frontotemporal dementia (FTD). Amyotrophic lateral sclerosis (ALS), the commonest form of MND and the third commonest form of neurodegenerative disease after Alzheimer’s and Parkinson’s, is currently incurable.


Carlo Rinaldi: Neuromuscular Translational Research

Laurent Servais: Specialised Translational Research Oxford Neuromuscular Group

Kevin Talbot: Oxford Motor Neuron Disease Centre

Martin Turner: FMRIB Neurodegeneration Group

Matthew Wood: Nucleic Acid Gene Therapy in Brain and Muscle